Prostaglandins and cardiovascular disease--a review.
D001095:Arachidonic Acids / Q000378:metabolism; D001161:Arteriosclerosis / Q000209:etiology; D002318:Cardiovascular Diseases / Q000503:physiopathology*; D002561:Cerebrovascular Disorders / Q000188:drug therapy; D003327:Coronary Disease / Q000188:drug therapy; D011464:Epoprostenol / Q000627:therapeutic use; D005112:Extracorporeal Circulation; D005333:Fetus / Q000502:physiology; D006706:Homeostasis; D006801:Humans; D011448:Prostaglandin Antagonists / Q000627:therapeutic use; D011453:Prostaglandins / Q000009:adverse effects / Q000096:biosynthesis / Q000502:physiology*; D011655:Pulmonary Embolism / Q000188:drug therapy; D012769:Shock / Q000188:drug therapy; D013931:Thromboxanes / Q000627:therapeutic use
D001095:Arachidonic Acids; D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D013931:Thromboxanes; D011464:Epoprostenol